Recently, adropin, a newly-identified multifunctional secreted peptide encoded by the energy homeostasis-associated (Enho) gene, has been investigated for its potential role in the prediction of acute kidney disease-to-CKD transition and monitoring CKD progression [17,18,19]. Here, ENHO is linked to chronic kidney disease.